Genpact Net Working Capital vs Cash And Equivalents Analysis
G Stock | USD 46.19 0.37 0.81% |
Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Net Working Capital and its Cash And Equivalents accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Net Working Capital vs Cash And Equivalents
Net Working Capital vs Cash And Equivalents Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Net Working Capital account and Cash And Equivalents. At this time, the significance of the direction appears to have very week relationship.
The correlation between Genpact's Net Working Capital and Cash And Equivalents is 0.23. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Cash And Equivalents in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Net Working Capital and Cash And Equivalents is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Genpact Limited are associated (or correlated) with its Cash And Equivalents. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Equivalents has no effect on the direction of Net Working Capital i.e., Genpact's Net Working Capital and Cash And Equivalents go up and down completely randomly.
Correlation Coefficient | 0.23 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Net Working Capital
Cash And Equivalents
Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Genpact's Enterprise Value Multiple is most likely to slightly decrease in the upcoming years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.5B | 1.6B | 902.8M | Total Revenue | 4.0B | 4.4B | 4.5B | 2.4B |
Genpact fundamental ratios Correlations
Click cells to compare fundamentals
Genpact Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Genpact fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Total Stockholder Equity | 1.7B | 1.8B | 1.9B | 1.8B | 2.2B | 1.4B | |
Net Debt | 1.3B | 1.3B | 1.1B | 1.0B | 919.3M | 965.3M | |
Retained Earnings | 648.7M | 741.7M | 732.5M | 780.0M | 1.1B | 1.1B | |
Cash | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 449.6M | |
Other Assets | 478.8M | 961.1M | 667.3M | 439.6M | 1.0 | 0.95 | |
Cash And Short Term Investments | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 472.7M | |
Common Stock Shares Outstanding | 195.2M | 195.8M | 193.0M | 188.1M | 185.1M | 200.1M | |
Liabilities And Stockholders Equity | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Other Stockholder Equity | 1.6B | 1.6B | 1.7B | 1.8B | 1.9B | 1.3B | |
Total Liab | 2.8B | 3.0B | 3.1B | 2.8B | 2.6B | 1.6B | |
Total Current Assets | 1.6B | 1.7B | 1.9B | 1.8B | 1.9B | 1.2B | |
Short Long Term Debt Total | 1.8B | 1.9B | 2.0B | 1.7B | 1.5B | 950.6M | |
Other Current Liab | 629.7M | 634.0M | 612.3M | 614.8M | 635.9M | 457.9M | |
Total Current Liabilities | 910.2M | 1.2B | 1.3B | 1.1B | 1.3B | 758.6M | |
Other Liab | 192.2M | 239.9M | 249.2M | 208.0M | 239.2M | 192.5M | |
Property Plant And Equipment Net | 584.9M | 535.8M | 485.7M | 379.1M | 393.7M | 285.6M | |
Current Deferred Revenue | 97.3M | 154.7M | 160.6M | 160.6M | 112.4M | 77.9M | |
Accounts Payable | 22.0M | 13.9M | 25.0M | 35.8M | 27.7M | 20.2M | |
Non Current Assets Total | 2.9B | 3.1B | 3.1B | 2.8B | 2.9B | 1.9B | |
Non Currrent Assets Other | 217.1M | 323.8M | 322.2M | 450.5M | 384.0M | 213.2M | |
Long Term Debt | 1.3B | 1.3B | 1.3B | 1.2B | 824.7M | 690.1M | |
Net Receivables | 914.3M | 892.7M | 899.0M | 1.0B | 1.1B | 615.0M | |
Good Will | 1.6B | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B | |
Common Stock Total Equity | 1.9M | 1.9M | 1.8M | 1.8M | 1.6M | 2.6M | |
Non Current Liabilities Total | 1.9B | 1.8B | 1.8B | 1.7B | 1.2B | 966.8M | |
Inventory | 121.2M | 150.1M | 103.7M | 1.0 | (137.5M) | (130.6M) | |
Other Current Assets | 49.2M | 175.7M | 123.1M | 123.1M | 174.1M | 182.8M | |
Property Plant And Equipment Gross | 618.4M | 585.9M | 485.7M | 379.1M | 984.1M | 1.0B | |
Accumulated Other Comprehensive Income | (532.0M) | (545.3M) | (554.4M) | (733.1M) | (722.6M) | (686.4M) | |
Short Term Debt | 161.2M | 358.1M | 463.6M | 246.8M | 503.4M | 528.6M | |
Intangible Assets | 230.9M | 236.7M | 169.6M | 89.7M | 53.0M | 50.4M | |
Common Stock | 1.9M | 1.9M | 1.8M | 1.8M | 1.8M | 2.5M | |
Property Plant Equipment | 254.0M | 231.1M | 485.7M | 379.1M | 436.0M | 238.5M | |
Short Term Investments | 1.8M | 8.8M | 5.8M | 5.4M | 4.4M | 4.2M | |
Net Tangible Assets | (116.2M) | (98.2M) | (3.5M) | 52.2M | 47.0M | 44.7M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Data Processing & Outsourced Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.156 | Dividend Share 0.595 | Earnings Share 3.64 | Revenue Per Share 25.964 | Quarterly Revenue Growth 0.066 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.